Arcadia Biosciences announces planned IPO, but licensing model could spook investors

Arcadia Biosciences, a California-based agricultural biotechnology firm, announced on February 27, 2015 that it filed a registration statement with the U.S. Security and Exchange Commission (SEC) for its proposed initial public offering (IPO) of common stock. The Form S-1 submitted by the company...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email Thank you!

Related Research

Solynta, disruptor in the potato seed industry, raises €21 million to expand true potato seeds (TPS)

News Commentary | July 30, 2021

Solynta, a Netherlands‑based company, raised €21 million in Series C funding to accelerate the full potential of true potato seeds (TPS). Potatoes are predominantly clonally propagated using tubers. Seeds from the potato berries are called true potato seeds. Solynta's innovative F1 hybrid breeding ... Not part of subscription

AgBiome raises $116 million Series D led by Blue Horizon

News Commentary | September 16, 2021

With the funding, AgBiome will expand its portfolio, cement its global presence, and scale its scientific and commercial teams. AgBiome has now generated two products with its discovery platform: Howler, a broad‑spectrum fungicide with 10× sales growth in 2020, and Theia, a second fungicide ... Not part of subscription

Marrone Bio Innovation merging with Bioceres Crop Solutions is an smart strategy for biological product portfolio expansion

Case Study | May 12, 2022

In March 2022, Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (Bioceres) and Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced that they would merge in an all‑stock transaction. Bioceres also recently acquired Rizobacter, an established biological and chemical solutions platform for crop ... Not part of subscription